The store will not work correctly when cookies are disabled.
N-{2-[2-(2,4-Dichloro-phenyl)-2-hydroxy-ethylamino]-ethyl}-isobutyramide HCl
ID: ALA1743670
PubChem CID: 54584691
Max Phase: Preclinical
Molecular Formula: C14H21Cl3N2O2
Molecular Weight: 319.23
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)C(=O)NCCNCC(O)c1ccc(Cl)cc1Cl.Cl
Standard InChI: InChI=1S/C14H20Cl2N2O2.ClH/c1-9(2)14(20)18-6-5-17-8-13(19)11-4-3-10(15)7-12(11)16;/h3-4,7,9,13,17,19H,5-6,8H2,1-2H3,(H,18,20);1H
Standard InChI Key: PNOYXWBVEUXWFQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 20 0 0 0 0 0 0 0 0999 V2000
1.4773 -4.7569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7648 -4.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4773 -4.3194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0523 -4.7569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4773 -5.5819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4773 -3.4944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1898 -4.3402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7648 -4.7402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0523 -5.5819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7606 -3.5194 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.1898 -4.7319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7648 -5.9944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6231 -4.3319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6644 -5.9944 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.1898 -3.5152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9023 -4.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0523 -4.3277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3398 -4.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1981 -5.5569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9106 -4.3194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4161 -7.8080 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 8 1 0
4 2 1 0
5 1 1 0
6 3 2 0
7 1 1 0
8 17 1 0
9 12 1 0
10 2 1 0
11 3 1 0
12 5 2 0
13 16 1 0
14 9 1 0
15 7 1 0
16 7 1 0
17 18 1 0
18 13 1 0
19 11 1 0
20 11 1 0
9 4 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 319.23 | Molecular Weight (Monoisotopic): 318.0902 | AlogP: 2.39 | #Rotatable Bonds: 7 |
Polar Surface Area: 61.36 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.83 | CX Basic pKa: 8.55 | CX LogP: 2.37 | CX LogD: 1.20 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.68 | Np Likeness Score: -0.88 |
References
1. Large MS, Smith LH.. (1980) Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanols., 23 (2): [PMID:6102152] [10.1021/jm00176a002] |